HomeCare March 18, 2025
With the acquisition of VeinoPlus, Dynapulse aims to increase the use of its Second Heart technology
MINNEAPOLIS, Minnesota—Dynapulse, an innovator in medical devices for circulatory and neuromuscular conditions, announced its acquisition of VeinoPlus, a company known for its solutions in electro-stimulation therapy. Dynapulse said this acquisition underscores its commitment to enhancing patient care and expanding its market presence with state-of-the-art health care technologies.
With the acquisition of VeinoPlus, Dynapulse aims to increase the use of its patented Second Heart technology with VeinoPlus’ advanced electro-stimulation solutions for symptoms of chronic venous insufficiency (CVI), peripheral arterial disease (PAD), deep vein thrombosis (DVT) prevention and other related medical conditions.
...Today's Sponsors
Today's Sponsor